Skip to main content
. 2023 Feb 11;61(1):427–436. doi: 10.1080/13880209.2023.2174145

Figure 1.

Figure 1.

Sanziguben polysaccharides (SZP) ameliorated renal injury in diabetic nephropathy (DN) mice after 8 weeks of administration. (A) Study flow diagram, (B) body weight, (C) water intake, (D) food intake, (E) fasting blood glucose (FBG), (F) serum insulin, (G) the homeostasis model assessment of insulin resistance (HOMA-IR) index, (H) triglyceride (TG), (I) total cholesterol (T-CHO), (J) urine albumin, (K) renal weight, (L) renal index, (M) serum creatinine (SCr), (N) blood urea nitrogen (BUN), (O) catalase (CAT), (P) superoxide dismutase (SOD), (Q) malondialdehyde (MDA), (R) histology (haematoxylin and eosin (H&E), periodic acid-Schiff (PAS), Masson and Sirius red staining). All data were expressed as the mean ± SD (n = 6). ##p< 0.01, ###p< 0.001 vs. NC group; *p< 0.05, **p< 0.01, ***p< 0.001 vs. DN group.